Kaplan & Sadock’s Synopsis of Psychiatry
Námskeið
- FRG108F Greining geðrænna vandkvæða.
Ensk lýsing:
Synopsis of Psychiatry: Behavorial Sciences/Clinical Psychiatry, 11th Edition is the only authoritative textbook for clinicians, residents, and students covering all psychiatric conditions. It is a complete, concise overview of the entire field of psychiatry, for psychiatrists in training and practice and all others who study and provide mental health care. Its multidisciplinary approach encompasses the biological, psychological and sociological factors at work in health and disease.
The latest information about specific diseases, psychopharmacotherapeutic and behavioral treatments and scientific research is incorporated into this revision. ICD (International Classification of Disease, World Health Organization) diagnostic criteria and numerical codes, used for reimbursement purposes, are included. Case studies throughout reinforce the clinical relevance of specific topics. The 11th edition is set apart from any other reference you have: • Contains DSM5 tables on every major psychiatric disorder • Use it to supplement the DSM5, offering current diagnostic and treatment protocols • Over 50 years of compounded knowledge in psychiatric medicine, offered by world-renowned experts.
Lýsing:
Accurate, reliable, objective, and comprehensive, Kaplan & Sadock’s Synopsis of Psychiatry has long been the leading clinical psychiatric resource for clinicians, residents, students, and other health care professionals both in the US and worldwide. Now led by a new editorial team of Drs. Robert Boland and Marcia L. Verduin, it continues to offer a trusted overview of the entire field of psychiatry while bringing you up to date with current information on key topics and developments in this complex specialty.
Annað
- Höfundur: Robert Boland
- Útgáfa:12
- Útgáfudagur: 2021-02-09
- Hægt að prenta út 2 bls.
- Hægt að afrita 2 bls.
- Format:ePub
- ISBN 13: 9781975145583
- Print ISBN: 9781975145569
- ISBN 10: 1975145585
Efnisyfirlit
- Cover
- Title Page
- Copyright
- Dedication
- Preface
- Contents
- A Clinical Psychiatry
- 1. Examination and Diagnosis of the Psychiatric Patient
- 1.1 The Adult Patient
- PSYCHIATRIC INTERVIEW, HISTORY, AND MENTAL STATUS EXAMINATION
- PHYSICAL EXAMINATION OF THE PSYCHIATRIC PATIENT
- THE PSYCHIATRIC REPORT AND MEDICAL RECORD
- PSYCHIATRIC RATING SCALES
- CLINICAL NEUROPSYCHOLOGY AND INTELLECTUAL ASSESSMENT OF ADULTS
- PERSONALITY ASSESSMENT: ADULTS AND CHILDREN
- MEDICAL ASSESSMENT AND LABORATORY TESTING IN PSYCHIATRY
- NEUROIMAGING
- 1.2 Children and Adolescents
- CLINICAL INTERVIEWS
- DIAGNOSTIC INSTRUMENTS
- QUESTIONNAIRES AND RATING SCALES
- COMPONENTS OF THE CHILD PSYCHIATRIC EVALUATION
- RECOMMENDATIONS AND TREATMENT PLAN
- INTELLECTUAL DISABILITY PSYCHIATRIC INTERVIEW AND TESTS
- 1.3 Geriatric Patients
- PSYCHIATRIC EXAMINATION OF THE OLDER PATIENT
- EARLY DETECTION AND PREVENTION STRATEGIES
- 1.1 The Adult Patient
- 1. Examination and Diagnosis of the Psychiatric Patient
- 2. Neurodevelopmental Disorders and Other Childhood Disorders
- 2.1 Intellectual Disability
- NOMENCLATURE
- CLASSIFICATION
- DEGREES OF SEVERITY OF INTELLECTUAL DISABILITY
- CLINICAL FEATURES
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 2.2 Communication Disorders
- LANGUAGE DISORDER
- SPEECH SOUND DISORDER
- CHILD-ONSET FLUENCY DISORDER (STUTTERING)
- SOCIAL (PRAGMATIC) COMMUNICATION DISORDER
- UNSPECIFIED COMMUNICATION DISORDER
- 2.3 Autism Spectrum Disorder
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOGENESIS
- 2.4 Attention-Deficit/Hyperactivity Disorder
- CLINICAL FEATURES
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- ADULT MANIFESTATIONS OF ADHD
- 2.5 Specific Learning Disorder
- SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN READING
- SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN MATHEMATICS
- SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN WRITTEN EXPRESSION
- 2.6 Motor Disorders
- DEVELOPMENTAL COORDINATION DISORDER
- STEREOTYPIC MOVEMENT DISORDER
- TOURETTES DISORDER
- PERSISTENT (CHRONIC) MOTOR OR VOCAL TIC DISORDER
- 2.7 Feeding and Eating Disorders of Infancy or Early Childhood
- PICA
- RUMINATION DISORDER
- AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER
- 2.8 Trauma- and Stressor-Related Disorders in Children
- REACTIVE ATTACHMENT DISORDER AND DISINHIBITED SOCIAL ENGAGEMENT DISORDER
- POSTTRAUMATIC STRESS DISORDER OF INFANCY, CHILDHOOD, AND ADOLESCENCE
- 2.9 Depressive Disorders and Suicide in Children and Adolescents
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- SUICIDE
- 2.10 Early-Onset Bipolar Disorder
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 2.11 Disruptive Mood Dysregulation Disorder
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- 2.12 Disruptive Behaviors of Childhood
- OPPOSITIONAL DEFIANT DISORDER
- CONDUCT DISORDER
- 2.13 Anxiety Disorders of Infancy, Childhood, and Adolescence: Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia)
- SEPARATION ANXIETY DISORDER
- GENERALIZED ANXIETY DISORDER
- SOCIAL ANXIETY DISORDER (SOCIAL PHOBIA)
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 2.14 Selective Mutism
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 2.15 Obsessive-Compulsive Disorder in Childhood and Adolescence
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 2.16 Early-Onset Schizophrenia
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- ATTENUATED PSYCHOSIS SYNDROME
- 2.17 Adolescent Substance Use Disorders
- DIAGNOSIS AND CLINICAL FEATURES
- COMORBIDITY
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 2.1 Intellectual Disability
- 3.1 Delirium
- DIAGNOSIS AND CLINICAL FEATURES
- PHYSICAL AND LABORATORY EXAMINATIONS
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 3.2 Dementia (Major Neurocognitive Disorder)
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 3.3 Major or Minor Neurocognitive Disorder due to Another Medical Condition (Amnestic Disorders)
- DIAGNOSIS
- CLINICAL FEATURES AND SUBTYPES
- PATHOLOGY AND LABORATORY EXAMINATION
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 3.4 Neurocognitive and Other Psychiatric Disorders due to a General Medical Condition
- SPECIFIC DISORDERS
- 3.5 Mild Cognitive Impairment
- DEFINITION
- CLINICAL PRESENTATION
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY AND ETIOLOGY OF MCI
- 4.1 General Features of the Substance-Related Disorders
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- COMORBIDITY
- TREATMENT APPROACH
- ETIOLOGY
- 4.2 Alcohol-Related Disorders
- DIAGNOSIS AND CLINICAL FEATURES
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT OF ALCOHOL USE DISORDERS
- PATHOLOGY
- ETIOLOGY
- 4.3 Cannabis-Related Disorders
- CLINICAL FEATURES
- DIAGNOSIS
- COMORBIDITY
- TREATMENT AND REHABILITATION
- EPIDEMIOLOGY
- PATHOLOGY
- 4.4 Opioid-Related Disorders
- CLINICAL FEATURES
- COMORBIDITY
- TREATMENT AND REHABILITATION
- EPIDEMIOLOGY
- PATHOLOGY
- ETIOLOGY
- 4.5 Sedative-, Hypnotic-, or Anxiolytic-Related Disorders
- DIAGNOSIS
- TREATMENT AND REHABILITATION
- EPIDEMIOLOGY
- PATHOLOGY
- 4.6 Stimulant-Related Disorders
- CLINICAL FEATURES
- DIAGNOSIS
- COMORBIDITY
- TREATMENT AND REHABILITATION
- EPIDEMIOLOGY
- PATHOLOGY
- ETIOLOGY
- 4.7 Tobacco-Related Disorders
- CLINICAL FEATURES
- DIAGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- PATHOLOGY
- 4.8 Caffeine-Related Disorders
- CLINICAL FEATURES AND DIAGNOSIS
- COMORBIDITY
- TREATMENT
- EPIDEMIOLOGY
- PATHOLOGY AND ETIOLOGY
- 4.9 Hallucinogen-Related Disorders
- CLINICAL FEATURES
- DIAGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- PATHOLOGY
- 4.10 Inhalant-Related Disorders
- CLINICAL FEATURES
- DIAGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- 4.11 Anabolic-Androgenic Steroid Use
- CLINICAL FEATURES AND DIAGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- PATHOLOGY
- ETIOLOGY
- 4.12 Gambling Disorder
- CLINICAL FEATURES
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- 4.13 Other Disorders Related to the Addictive Disorders
- INTERNET GAMING DISORDER
- MOBILE OR CELL PHONE COMPULSION
- REPETITIVE SELF-MUTILATION
- COMPULSIVE SEXUAL BEHAVIOR
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- OBJECTIVE TESTS FOR THE DISORDER
- DIFFERENTIAL DIAGNOSIS FOR PSYCHOTIC DISORDERS
- COMORBIDITY
- COURSE
- PROGNOSIS
- TREATMENT APPROACH
- THE EPIDEMIOLOGY OF THE DISORDERS
- THE NEUROBIOLOGY OF THE DISORDER
- THE PSYCHOLOGY OF THE DISORDER
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE
- PROGNOSIS
- TREATMENT APPROACH
- THE EPIDEMIOLOGY OF THE DISORDER(S)
- THE NEUROBIOLOGY OF THE DISORDER
- THE PSYCHOLOGY OF THE DISORDER
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE
- PROGNOSIS
- TREATMENT APPROACH
- THE EPIDEMIOLOGY OF DEPRESSION
- THE NEUROBIOLOGY OF DEPRESSION
- THE PSYCHOLOGY OF DEPRESSION
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE
- TREATMENT APPROACH
- THE EPIDEMIOLOGY OF THE DISORDER(S)
- THE NEUROBIOLOGY OF THE DISORDER
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS FOR THE TRAUMA- AND STRESSOR-RELATED DISORDERS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT APPROACH
- EPIDEMIOLOGY
- ETIOLOGY
- DIAGNOSTIC AND CLINICAL FEATURES
- DEPERSONALIZATION/DEREALIZATION DISORDER
- DISSOCIATIVE IDENTITY DISORDER
- OTHER SPECIFIED OR UNSPECIFIED DISSOCIATIVE DISORDER
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- EVALUATION OF SOMATIC SYMPTOM AND RELATED DISORDERS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT OF SOMATIC SYMPTOM AND RELATED DISORDERS
- EPIDEMIOLOGY
- ETIOLOGY
- CLINICAL FEATURES
- DIAGNOSIS AND CLINICAL FEATURES
- PATHOLOGY AND LABORATORY EXAMINATION
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT APPROACH
- EPIDEMIOLOGY
- ETIOLOGY
- ENCOPRESIS
- ENURESIS
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- CLINICAL TOOLS IN SLEEP MEDICINE
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- TREATMENT APPROACH
- SEXUAL DYSFUNCTIONS
- PARAPHILIC DISORDERS
- SEX ADDICTION AND COMPULSIVITY
- NORMAL SEXUALITY
- INTRODUCTION
- DIAGNOSIS AND CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- COURSE AND PROGNOSIS
- COMORBIDITY
- TREATMENT
- EPIDEMIOLOGY
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- OBJECTIVE TESTS FOR THE DISORDERS
- DIFFERENTIAL DIAGNOSIS FOR THE DISRUPTIVE AND IMPULSE-CONTROL DISORDERS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT APPROACH
- EPIDEMIOLOGY
- ETIOLOGY
- THE CLINICAL PRESENTATION
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- COMORBIDITY
- COURSE AND PROGNOSIS
- TREATMENT APPROACH
- EPIDEMIOLOGY
- ETIOLOGY
- INTRODUCTION
- MALINGERING
- BEREAVEMENT
- OCCUPATIONAL PROBLEMS
- ADULT ANTISOCIAL BEHAVIOR
- RELIGIOUS OR SPIRITUAL PROBLEM
- ACCULTURATION PROBLEM
- PHASE OF LIFE PROBLEM
- NONCOMPLIANCE WITH TREATMENT
- RELATIONAL PROBLEMS
- 21. Psychopharmacology
- 21.1 Antipsychotics
- SEROTONIN–DOPAMINE ANTAGONISTS AND SIMILARLY ACTING DRUGS (SECOND-GENERATION OR ATYPICAL ANTIPSYCHOTICS)
- DOPAMINE RECEPTOR ANTAGONISTS (FIRST-GENERATION ANTIPSYCHOTICS)
- 21.2 Antidepressants
- SELECTIVE SEROTONIN REUPTAKE INHIBITORS
- SELECTIVE SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS
- BUPROPION
- MIRTAZAPINE
- NEFAZODONE AND TRAZODONE
- TRICYCLICS AND TETRACYCLICS
- MONOAMINE OXIDASE INHIBITORS
- THYROID HORMONES
- NOVEL AGENTS
- 21.3 Mood Stabilizers
- LITHIUM
- VALPROATE
- LAMOTRIGINE
- CARBAMAZEPINE AND OXCARBAZEPINE
- OTHER ANTICONVULSANTS
- CALCIUM CHANNEL BLOCKERS
- 21.4 Anxiolytics
- BENZODIAZEPINES AND DRUGS ACTING ON GABA RECEPTORS
- BUSPIRONE
- β-ADRENERGIC RECEPTOR ANTAGONISTS
- BARBITURATES AND SIMILARLY ACTING DRUGS
- 21.5 Drugs Used to Treat Sleep Disorders
- NONBENZODIAZEPINE GABA AGONISTS
- MELATONIN AGONISTS: RAMELTEON AND MELATONIN
- PRAZOSIN
- 21.6 Stimulants
- STIMULANT DRUGS AND ATOMOXETINE
- ATOMOXETINE (STRATTERA)
- 21.7 Drugs Used to Treat Substance Use Disorders
- OPIOID RECEPTOR AGONISTS
- OPIOID RECEPTOR ANTAGONISTS: NALTREXONE, NALMEFENE, AND NALOXONE
- DISULFIRAM AND ACAMPROSATE
- CLONIDINE AND GUANFACINE
- 21.8 Drugs Used for Cognitive Enhancement
- CHOLINESTERASE INHIBITORS
- MEMANTINE
- 21.9 Drugs Used to Treat Sexual Disorders
- PHOSPHODIESTERASE-5 INHIBITORS
- YOHIMBINE
- 21.10 Drugs Used to Treat the Side Effects of Psychotropic Drugs
- ANTICHOLINERGIC AGENTS
- ANTIHISTAMINES
- DOPAMINE RECEPTOR AGONISTS AND PRECURSORS
- DRUGS TO TREAT PSYCHOTROPIC-INDUCED WEIGHT GAIN
- 21.11 Nutritional Supplements and Related
- NUTRITIONAL SUPPLEMENTS AND MEDICAL FOODS
- PHYTOMEDICINES
- 21.1 Antipsychotics
- ELECTROCONVULSIVE THERAPY
- OTHER BRAIN STIMULATION METHODS
- NEUROSURGICAL TREATMENTS AND DEEP BRAIN STIMULATION
- PSYCHOANALYSIS AND PSYCHOANALYTIC PSYCHOTHERAPY
- BRIEF PSYCHODYNAMIC PSYCHOTHERAPY
- GROUP PSYCHOTHERAPY, COMBINED INDIVIDUAL AND GROUP PSYCHOTHERAPY, AND PSYCHODRAMA
- FAMILY THERAPY AND COUPLES THERAPY
- DIALECTICAL BEHAVIOR THERAPY
- BIOFEEDBACK
- COGNITIVE THERAPY
- BEHAVIOR THERAPY
- HYPNOSIS
- INTERPERSONAL THERAPY
- NARRATIVE PSYCHOTHERAPY
- COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY
- MENTALIZATION-BASED TREATMENT
- PSYCHOEDUCATIONAL INTERVENTIONS
- PSYCHIATRIC REHABILITATION
- GENETIC COUNSELING
- 25.1 Consultation-Liaison Psychiatry
- HISTORY
- CURRENT TRENDS
- EVALUATION PROCESS IN PSYCHOSOMATIC MEDICINE
- TREATMENTS USED IN PSYCHOSOMATIC MEDICINE
- PSYCHO-ONCOLOGY
- 25.2 Geriatric Psychiatry
- PSYCHIATRIC PROBLEMS OF OLDER PERSONS
- MENTAL DISORDERS OF OLD AGE
- SUICIDE RISK
- OTHER CONDITIONS OF OLD AGE
- SPOUSAL BEREAVEMENT
- PSYCHOPHARMACOLOGICAL TREATMENT OF GERIATRIC DISORDERS
- PSYCHOTHERAPY FOR GERIATRIC PATIENTS
- 25.3 Psychiatric Emergencies
- TREATMENT SETTINGS
- EPIDEMIOLOGY
- EVALUATION
- SPECIFIC INTERVIEW SITUATIONS
- TREATMENT OF EMERGENCIES
- PSYCHIATRIC EMERGENCIES IN CHILDREN
- INPATIENT ADMISSION
- PARTIAL HOSPITAL TREATMENT
- INTENSIVE OUTPATIENT TREATMENT
- OUTPATIENT CARE
- RESIDENTIAL CARE
- 27. Ethics and Professionalism
- PROFESSIONAL CODES
- BASIC ETHICAL PRINCIPLES
- SPECIFIC ISSUES
- 28. Forensic and Legal Issues
- MEDICAL MALPRACTICE
- PRIVILEGE AND CONFIDENTIALITY
- HIGH-RISK CLINICAL SITUATIONS
- HOSPITALIZATION
- RIGHT TO TREATMENT
- RIGHT TO REFUSE TREATMENT
- CIVIL RIGHTS OF PATIENTS
- SECLUSION AND RESTRAINT
- INFORMED CONSENT
- CHILD CUSTODY
- TESTAMENTARY AND CONTRACTUAL CAPACITY AND COMPETENCE
- CRIMINAL LAW
- OTHER AREAS OF FORENSIC PSYCHIATRY
- 29. End-of-Life Issues and Palliative Care
- 29.1 Death, Dying, and Bereavement
- DEATH AND DYING
- BEREAVEMENT, GRIEF, AND MOURNING
- LIFE CYCLE PERSPECTIVES ABOUT BEREAVEMENT
- 29.2 Palliative Care
- PREVALENCE
- GENERAL TREATMENT PRINCIPLES
- ANXIETY IN PATIENTS WITH ADVANCED DISEASE
- DEPRESSION IN PATIENTS WITH ADVANCED DISEASE
- CONFUSIONAL STATES IN PATIENTS WITH ADVANCED DISEASE
- DISEASE-SPECIFIC CONSIDERATIONS
- PATIENT–FAMILY UNIT
- DECISION POINTS, ADVANCE DIRECTIVES, PROXIES, AND SURROGATES
- CARING FOR THE DYING PATIENT
- COMMUNICATION
- TERMINAL CARE DECISIONS
- CARING FOR THE FAMILY
- PALLIATIVE CARE
- PAIN MANAGEMENT
- PALLIATION OF OTHER SYMPTOMS
- HOSPICE CARE
- NEONATAL AND INFANT END-OF-LIFE CARE
- CHILD END-OF-LIFE CARE
- SPIRITUAL ISSUES
- ALTERNATIVE AND COMPLEMENTARY MEDICINE
- 29.3 Euthanasia and Physician-Assisted Suicide
- EUTHANASIA
- PHYSICIAN-ASSISTED SUICIDE
- FUTURE DIRECTIONS
- 29.1 Death, Dying, and Bereavement
- INTRODUCTION
- CONTEMPORARY PUBLIC AND COMMUNITY PSYCHIATRY
- THE ROLE OF PUBLIC AND COMMUNITY PSYCHIATRY IN TWENTY-FIRST CENTURY HEALTH CARE
- PREVALENCE AND BURDEN OF MENTAL DISORDERS WORLDWIDE
- TREATMENT GAP AND PROJECTED POPULATION-LEVEL TREATMENT EFFECTIVENESS WORLDWIDE
- RESOURCES FOR MENTAL HEALTH CARE WORLDWIDE
- PRINCIPLES FOR MENTAL HEALTH PROGRAM DEVELOPMENT AND BARRIERS TO CHANGE WORLDWIDE
- STIGMATIZING ATTITUDES TOWARD PEOPLE WITH MENTAL DISORDERS
- RELATIONSHIPS BETWEEN MENTAL AND PHYSICAL DISEASES
- ETHICAL ISSUES IN MENTAL HEALTH CARE
- INTERNATIONAL ORGANIZATIONS ACTIVE IN THE MENTAL HEALTH FIELD
- FUTURE PERSPECTIVES
- 32. Normal Development and Aging
- 32.1 Infant, Child, and Adolescent Development
- PRENATAL, INFANT, AND CHILD
- PRENATAL
- INFANCY
- TODDLER PERIOD
- PRESCHOOL PERIOD
- MIDDLE YEARS
- ADOLESCENCE
- 32.2 Adulthood
- INTRODUCTION
- YOUNG ADULTHOOD (20 TO 40 YEARS OF AGE)
- MIDDLE ADULTHOOD (40 TO 65 YEARS OF AGE)
- DIVORCE
- ADULT MATURITY
- 32.3 Old Age
- DEMOGRAPHICS
- BIOLOGY OF AGING
- STAGE THEORIES OF PERSONALITY DEVELOPMENT
- PSYCHOSOCIAL ASPECTS OF AGING
- 32.1 Infant, Child, and Adolescent Development
- THE HUMAN BRAIN
- FUNCTIONAL NEUROANATOMY
- NEURAL DEVELOPMENT AND NEUROGENESIS
- NEUROPHYSIOLOGY AND NEUROCHEMISTRY
- PSYCHONEUROENDOCRINOLOGY
- IMMUNE SYSTEM AND CENTRAL NERVOUS SYSTEM INTERACTIONS
- NEUROGENETICS
- APPLIED ELECTROPHYSIOLOGY
- CHRONOBIOLOGY
- 34.1 Contributions from the Psychosocial Sciences
- JEAN PIAGET AND COGNITIVE DEVELOPMENT
- ATTACHMENT THEORY
- LEARNING THEORY
- BIOLOGY OF MEMORY
- MULTIPLE TYPES OF MEMORY
- NEUROIMAGING AND MEMORY
- SLEEP AND MEMORY
- ASSESSMENT OF MEMORY FUNCTIONS
- IMPLICATIONS
- 34.2 Normality and Mental Health
- DEFINING MENTAL HEALTH
- MODELS OF MENTAL HEALTH
- 34.3 Contributions from the Sociocultural Sciences
- SOCIOBIOLOGY AND ETHOLOGY
- TRANSCULTURAL PSYCHIATRY
- CULTURE-BOUND SYNDROMES
- 34.4 Theories of Personality and Psychopathology
- SIGMUND FREUD: FOUNDER OF CLASSIC PSYCHOANALYSIS
- ERIK H. ERIKSON
- OTHER PSYCHODYNAMIC SCHOOLS
- POSITIVE PSYCHOLOGY
- PSYCHIATRY BEFORE THE MODERN ERA
- PSYCHIATRY IN THE MODERN AGE
- DEINSTITUTIONALIZATION
- THE CLASSIFICATION OF PSYCHIATRIC DISORDERS
- LOOKING TO THE FUTURE
UM RAFBÆKUR Á HEIMKAUP.IS
Bókahillan þín er þitt svæði og þar eru bækurnar þínar geymdar. Þú kemst í bókahilluna þína hvar og hvenær sem er í tölvu eða snjalltæki. Einfalt og þægilegt!Rafbók til eignar
Rafbók til eignar þarf að hlaða niður á þau tæki sem þú vilt nota innan eins árs frá því bókin er keypt.
Þú kemst í bækurnar hvar sem er
Þú getur nálgast allar raf(skóla)bækurnar þínar á einu augabragði, hvar og hvenær sem er í bókahillunni þinni. Engin taska, enginn kyndill og ekkert vesen (hvað þá yfirvigt).
Auðvelt að fletta og leita
Þú getur flakkað milli síðna og kafla eins og þér hentar best og farið beint í ákveðna kafla úr efnisyfirlitinu. Í leitinni finnur þú orð, kafla eða síður í einum smelli.
Glósur og yfirstrikanir
Þú getur auðkennt textabrot með mismunandi litum og skrifað glósur að vild í rafbókina. Þú getur jafnvel séð glósur og yfirstrikanir hjá bekkjarsystkinum og kennara ef þeir leyfa það. Allt á einum stað.
Hvað viltu sjá? / Þú ræður hvernig síðan lítur út
Þú lagar síðuna að þínum þörfum. Stækkaðu eða minnkaðu myndir og texta með multi-level zoom til að sjá síðuna eins og þér hentar best í þínu námi.
Fleiri góðir kostir
- Þú getur prentað síður úr bókinni (innan þeirra marka sem útgefandinn setur)
- Möguleiki á tengingu við annað stafrænt og gagnvirkt efni, svo sem myndbönd eða spurningar úr efninu
- Auðvelt að afrita og líma efni/texta fyrir t.d. heimaverkefni eða ritgerðir
- Styður tækni sem hjálpar nemendum með sjón- eða heyrnarskerðingu
- Gerð : 208
- Höfundur : 16618
- Útgáfuár : 2021
- Leyfi : 379